Thyrotoxicosis

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00085955" target="_blank" >RIV/00023001:_____/25:00085955 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00023001:_____/21:00081915

Výsledek na webu

<a href="https://doi.org/10.1016/j.mpmed.2025.06.012" target="_blank" >https://doi.org/10.1016/j.mpmed.2025.06.012</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.mpmed.2025.06.012" target="_blank" >10.1016/j.mpmed.2025.06.012</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Thyrotoxicosis

Popis výsledku v původním jazyce

Thyrotoxicosis refers to symptoms and signs that arise from excess quantities of circulating thyroid hormones. It can be caused by hyperthyroidism – hyperfunction of the thyroid gland – or by other mechanisms, such as the destruction of thyroid follicles with release of thyroid hormones (thyroiditis) or excessive ingestion of thyroid hormones (thyrotoxicosis factitia). There are several causes of thyrotoxicosis, the most common being Graves&apos; disease, followed by toxic nodular thyroid disease (toxic multinodular goitre, toxic adenoma) and thyroiditis of any aetiology. Establishing the underlying cause of thyrotoxicosis is essential for its management. Diagnosis relies on clinical observation, sensitive hormonal and immunological assays and the occasional use of thyroid scintigraphy. Management of thyrotoxicosis includes the use of anti-thyroid medication, β-adrenoceptor blocking agents, radioiodine, thyroid surgery or a combination of these. Management of thyrotoxicosis in pregnancy and the postpartum period requires special attention and expertise as the correct diagnosis and treatment can significantly influence the outcome of pregnancy and the well-being of the mother and the fetus or newborn.

Název v anglickém jazyce

Thyrotoxicosis

Popis výsledku anglicky

Thyrotoxicosis refers to symptoms and signs that arise from excess quantities of circulating thyroid hormones. It can be caused by hyperthyroidism – hyperfunction of the thyroid gland – or by other mechanisms, such as the destruction of thyroid follicles with release of thyroid hormones (thyroiditis) or excessive ingestion of thyroid hormones (thyrotoxicosis factitia). There are several causes of thyrotoxicosis, the most common being Graves&apos; disease, followed by toxic nodular thyroid disease (toxic multinodular goitre, toxic adenoma) and thyroiditis of any aetiology. Establishing the underlying cause of thyrotoxicosis is essential for its management. Diagnosis relies on clinical observation, sensitive hormonal and immunological assays and the occasional use of thyroid scintigraphy. Management of thyrotoxicosis includes the use of anti-thyroid medication, β-adrenoceptor blocking agents, radioiodine, thyroid surgery or a combination of these. Management of thyrotoxicosis in pregnancy and the postpartum period requires special attention and expertise as the correct diagnosis and treatment can significantly influence the outcome of pregnancy and the well-being of the mother and the fetus or newborn.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

30202 - Endocrinology and metabolism (including diabetes, hormones)

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Medicine (UK)

ISSN

1357-3039

e-ISSN

1878-9390

Svazek periodika

53

Číslo periodika v rámci svazku

9

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

7

Strana od-do

617-623

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-105011661965